NASDAQ / LIVE COMPANY INTELLIGENCE

Vera Therapeutics, Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERVERA
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / VERA COVERAGE

What’s moving Vera Therapeutics, Inc. now

Current reporting with the operating signal separated from the noise.

01
Is Vera Therapeutics, Inc. (VERA) A Good Stock To Buy Now?

Is Vera Therapeutics, Inc. (VERA) A Good Stock To Buy Now?

Investors are testing whether Vera Therapeutics, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
02
Vera Therapeutics, Inc. (VERA) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Vera Therapeutics, Inc. (VERA) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

The story matters when it changes Vera Therapeutics, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
03
Vera Therapeutics, Inc. (VERA) Discusses Interim Results of ORIGIN Phase 3 Trial of Atacicept for IgA Nephropathy Transcript

Vera Therapeutics, Inc. (VERA) Discusses Interim Results of ORIGIN Phase 3 Trial of Atacicept for IgA Nephropathy Transcript

The story matters when it changes Vera Therapeutics, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
04
Why Vera Therapeutics, Inc. (VERA) Skyrocketed On Monday

Why Vera Therapeutics, Inc. (VERA) Skyrocketed On Monday

The story matters when it changes Vera Therapeutics, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
05
Vera Therapeutics, Inc.

Vera Therapeutics, Inc.

The story matters when it changes Vera Therapeutics, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest VERA filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-05-07 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-05 · Period 2025-09-30SEC ↗10-KAnnual financial reportFiled 2026-02-26 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-07-09 · Period 2026-07-09SEC ↗8-KMaterial company eventFiled 2026-07-07 · Period 2026-07-07SEC ↗8-KMaterial company eventFiled 2026-06-02 · Period 2026-06-02SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-04-09 · Period 2026-05-21SEC ↗SCHEDULE 13G/AOfficial SEC filingFiled 2026-07-30SEC ↗
EARNINGS / QUARTERLY TRACKER

Vera Therapeutics, Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.